Nedocromil

CHEMBL746 Phase 4 Approuvé Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
371.3 g/mol
LogP
2.2
Phase
4

This anti-inflammatory medication is used as an inhaler to prevent asthma attacks and as eye drops to treat allergic eye conditions. It works by stabilizing mast cells in the airways and eyes, preventing them from releasing chemicals that trigger allergy and asthma symptoms.

Masse moléculaire

371,3000 g/mol

LogP

2,20

TPSA

121,00 Ų

Règle des 5 de Lipinski

Conforme

Aires thérapeutiques

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCCc1c2oc(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)n(CC)c12

InChI

InChI=1S/C19H17NO7/c1-3-5-9-16-10(13(21)7-12(18(23)24)20(16)4-2)6-11-14(22)8-15(19(25)26)27-17(9)11/h6-8H,3-5H2,1-2H3,(H,23,24)(H,25,26)

Molecular Formula

C19H17NO7

HBD / HBA

2 / 8

Liaisons Rotatives

5

Atomes Lourds

27

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

This anti-inflammatory medication is used as an inhaler to prevent asthma attacks and as eye drops to treat allergic eye conditions. It works by stabilizing mast cells in the airways and eyes, preventing them from releasing chemicals that trigger allergy and asthma symptoms.

Yes, Nedocromil is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL746. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 50294. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.